802 articles
XellSmart's XS411 transplants lab-grown dopamine neurons into Parkinson's brains, showing early motor gains and no adverse events.
Life Time's SpiroFit brings lab-grade VO₂ max and metabolic testing to everyday gym-goers, turning a key longevity biomarker into actionable fitness data.
Mesoblast licenses CAR technology to make its stem cell therapies smarter at finding inflamed tissue, targeting IBD and autoimmune disease.
BioAge's oral NLRP3 inhibitor BGE-102 cut hsCRP by ~85% in weeks, signaling a potential breakthrough in treating chronic inflammation at scale.
New research shows lifespan growth has nearly plateaued in wealthy nations, prompting calls for a systems-level rethink of aging science.
A protein called HOXD13 drives skin cancer growth and shields tumors from immune cells — disabling it could unlock powerful new treatments.
New evidence suggests 500mg daily vitamin C cuts anxiety within two weeks, but whole fruits may offer safer, broader benefits.
A single CAR-T cell infusion drove complete remission in all 20 high-risk smoldering myeloma patients, raising hopes of a one-and-done cure.
New research links exercise timing to your body clock, confirms oral GLP-1 heart safety, and flags prediabetes as an AFib risk factor.
Tirzepatide outperforms semaglutide on weight loss but may strip more muscle. Plus: fructose, keto diets, and cardiac benefits of oral GLP-1s.
Elisrasib achieved 60% response rates in treatment-naive NSCLC patients and helped one-third who failed prior KRAS therapies.
A large insurance claims study of 350,000 IBD patients finds NSAID use poses little to no flare risk for ulcerative colitis patients.
